Improved outcome of patients with mantle cell lymphoma (MCL) in first remission (CRI) after hematopoietic stem cell transplantation

被引：0
|
作者：
Kassim, A. [1 ]
Jagasia, M. [1 ]
Dixon, S. [1 ]
Chinratanalab, W. [1 ]
Morgan, D. [1 ]
Ruffner, K. [1 ]
Greer, J. [1 ]
Stein, R. [1 ]
Engelhardt, B. [1 ]
机构：
[1] Vanderbilt Univ, Nashville, TN 37235 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2007年 / 13卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2006.12.151
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
147
引用
收藏
页码：55 / 55
页数：1
相关论文
共 50 条
  • [41] Does the intensity of the induction regimen prior to autologous hematopoietic stem cell transplantation (HSCT) affect long-term outcome for patients with newly diagnosed mantle cell lymphoma (MCL)?
    Madan, RA
    Rowley, SD
    Goldberg, SL
    Hsu, JW
    Pecora, AL
    BLOOD, 2003, 102 (11) : 489B - 489B
  • [42] The outcome and characteristics of patients with relapsed adult T cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation
    Kato, Koji
    Uike, Naokuni
    Wake, Atsushi
    Yoshimitsu, Makoto
    Tobai, Tomomi
    Sawayama, Yasushi
    Takatsuka, Yoshifusa
    Fukuda, Takahiro
    Uchida, Naoyuki
    Eto, Tetsuya
    Nakashima, Yasuhiro
    Kondo, Tadakazu
    Taguchi, Jun
    Miyamoto, Toshihiro
    Nakamae, Hirohisa
    Ichinohe, Tatsuo
    Kato, Koji
    Suzuki, Ritsuro
    Utsunomiya, Atae
    HEMATOLOGICAL ONCOLOGY, 2019, 37 (01) : 54 - 61
  • [43] COMPLEX KARYOTYPE (CK) IS ASSOCIATED WITH INCREASED CUMULATIVE INCIDENCE OF RELAPSE (CIR) FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) FOR MANTLE CELL LYMPHOMA (MCL) IN FIRST REMISSION
    Cohen, J. B.
    Ruppert, A. S.
    Kaplan, L. D.
    Baiocchi, R.
    Porcu, P.
    Flynn, J.
    Penza, S.
    Jones, J. A.
    Blum, K. A.
    Devine, S. M.
    Andritsos, L. A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S205 - S206
  • [44] Is Early Hematopoietic Stem-Cell Transplantation Necessary in Mantle-Cell Lymphoma?
    Smith, Mitchell R.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04) : 265 - 267
  • [45] Long-Term Remission After Hematopoietic Stem Cell Transplantation for Refractory Cutaneous T Cell Lymphoma
    Galvin, John P.
    Monreal, Joanne
    Guitart, Joan
    Rosen, Steve T.
    Kuzel, Timothy
    Mehta, Jayesh
    BLOOD, 2012, 120 (21)
  • [46] Outcome of patients with mantle cell lymphoma after autologous stem cell transplantation in the pre-CAR T-cell era
    Mathys, Anina
    Bacher, Ulrike
    Banz, Yara
    Legros, Myriam
    Mansouri Taleghani, Behrouz
    Novak, Urban
    Pabst, Thomas
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (02) : 292 - 296
  • [47] Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study
    Pott, Christiane
    Hoster, Eva
    Delfau-Larue, Marie-Helene
    Beldjord, Kheira
    Boettcher, Sebastian
    Asnafi, Vahid
    Plonquet, Anne
    Siebert, Reiner
    Callet-Bauchu, Evelyne
    Andersen, Niels
    van Dongen, Jacques J. M.
    Klapper, Wolfram
    Berger, Francoise
    Ribrag, Vincent
    van Hoof, Achiel L.
    Trneny, Marek
    Walewski, Jan
    Dreger, Peter
    Unterhalt, Michael
    Hiddemann, Wolfgang
    Kneba, Michael
    Kluin-Nelemans, Hanneke C.
    Hermine, Olivier
    Macintyre, Elizabeth
    Dreyling, Martin
    BLOOD, 2010, 115 (16) : 3215 - 3223
  • [48] Treatment of AML in First Remission (CRI) with Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Using Unrelated Donors (UD).
    Silva, Leandro de Padua
    Andersson, Borje S.
    Popat, Uday
    Griffin, Lori
    Alvarez, Michele
    Patah, Poliana
    Parmar, Simrit
    Giralt, Sergio
    Rondon, Gabriela
    Fernandez-Vina, Marcelo
    Cano, Pedro
    Champlin, Richard E.
    De Lima, Marcos
    BLOOD, 2008, 112 (11) : 359 - 360
  • [49] Mantle cell lymphoma in first complete remission
    Laport, Ginna G.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (09) : 1118 - 1119
  • [50] Mantle cell lymphoma in patients not eligible for autologous stem cell transplantation
    Aurer, Igor
    CURRENT OPINION IN ONCOLOGY, 2019, 31 (05) : 374 - 379
12345